Company intelligence / Profile preview

LCY Biosciences

Sarnia, Ontario, Canada

Ownership: Private
Employees: ~65
Development stage: Other

Overview

LCY Biosciences operates a commercial-scale fermentation facility producing bio-based succinic acid and carotenoids (including astaxanthin and beta carotene) from renewable feedstocks for use in food ingredients, dietary supplements, pharmaceuticals, and specialty chemicals; development work and regulatory submissions for carotenoids are ongoing with customer qualifications already achieved.[2][6][7]

Therapeutic areas: OtherGastroenterologyMetabolic Disorders
Modalities: Small moleculeMicrobial therapyLive biotherapeutic product therapy
Industry: Non-Drug Biotech

Partnerships

Bioindustrial Innovation Canada (BIC)[2][7]Lambton College Research and Innovation Centre[2][7]Western Sarnia-Lambton Research Park (planned collaboration)[2]Sarnia-Lambton Economic Partnership (regional development support)[6]

Beyond the preview

Go deeper on LCY Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LCY Biosciences.

Explore the full profile